Effects of Peritoneal dialysis solutions low in GDPs on peritonitis and exit-site infection rates

Peritoneal Dialysis International

Volumn 28, Issue 6, 2008, Pages 637-640

  Furkert, Jürgen D ^a   Zeier, Martin ^b   Schwenger, Vedat ^b  

^a SLK Kliniken Heilbronn   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Dialysis solutions; Exit site infections; Peritonitis

Indexed keywords

DIALYSIS FLUID; GLUCOSE DEGRADATION PRODUCT; GLUCOSE;

ADULT; ARTICLE; BACTERIAL PERITONITIS; BIOCOMPATIBILITY; CATHETER EXIT SITE INFECTION; CATHETER INFECTION; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; DIALYSATE; FEMALE; HUMAN; INCIDENCE; INFECTION RATE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; PERITONITIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK REDUCTION; STAPHYLOCOCCUS EPIDERMIDIS; TREATMENT DURATION; CHEMISTRY; CHRONIC KIDNEY FAILURE; DIABETIC NEPHROPATHY; INDWELLING CATHETER; METABOLISM; MICROBIOLOGY; MIDDLE AGED; PERITONEAL DIALYSIS; SURGICAL INFECTION;

ADULT; CATHETERS, INDWELLING; DIABETIC NEPHROPATHIES; DIALYSIS SOLUTIONS; FEMALE; GLUCOSE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PERITONITIS; RETROSPECTIVE STUDIES; SURGICAL WOUND INFECTION;

EID: 60249095758     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080802800616     Document Type: Article

References (14)

1. Cooker LA, Luneburg P, Faict D, Choo C, Holmes CJ. Reduced glucose degradation products in bicarbonate/lactate-buffered peritoneal dialysis solutions produced in two-chambered bags. Perit Dial Int 1997; 17:373-8.
2. Do J, Kim Y, Park J, Cho K, Kim T, Yoon K, et al. The effect of low degradation product dialysis solution on epithelial-to-mesenchymal transition in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 2005; 25(Suppl 3):S22-5.
3. Witowski J, Korybalska K, Ksiazek K, Wisniewska-Elnur J, Jörres A, Lage C, et al., and the members of the European Balance Trial Group. Peritoneal dialysis with solutions low in glucose degradation products is associated with improved biocompatibility profile towards peritoneal mesothelial cells. Nephrol Dial Transplant 2004; 19:917-24.
4. Wieczorowska-Tobis K, Brelinska R, Witowski J, Passlick-Deetjen J, Schaub TP, Schilling H, et al. Evidence for less irritation to the peritoneal membrane in rats dialyzed with solutions low in glucose degradation products. Perit Dial Int 2004; 24:48-57.
5. Park S, Lee E, Kim I, Kim YJ, Cho D, Kim YL. Effect of glucose degradation products on the peritoneal membrane in a chronic inflammatory infusion model of peritoneal dialysis in the rat. Perit Dial Int 2004; 24:115-22.
6. Witowski J, Jörres A, Korybalska K, Ksiazek K, Wisniewska-Elnur J, Bender TO, et al. Glucose degradation products in peritoneal dialysis fluids: do they harm? Kidney Int Suppl 2003; 84:S148-51.
7. Zeier M, Schwenger V, Deppisch R, Haug U, Weigel K, Bahner U, et al. Glucose degradation products in PD fluids: do they disappear from the peritoneal cavity and enter the systemic circulation? Kidney Int 2003; 63:298-305.
8. Rippe B, Simonsen O, Heimbürger O, Christensson A, Haraldsson B, Stelin G, et al. Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products. Kidney Int 2001; 59:348-57.
9. Lee GS, Woo KT. Infection in continuous ambulatory peritoneal dialysis (CAPD): aetiology, complications and risk factors. Ann Acad Med Singapore 1992; 21:354-60.
10. Witowski J, Wisniewska J, Korybalska K, Bender TO, Breborowicz A, Gahl GM, et al. Prolonged exposure to glucose degradation products impairs viability and function of human peritoneal mesothelial cells. J Am Soc Nephrol 2001; 12:2434-41.
11. Alscher DM, Pauli-Magnus C, Kirchgessner J, Kuhlmann U, Mettang T. A new lactate-based, plasticizer-free, neutral peritoneal dialysis fluid provided in a two-compartment system: effect on peripheral leukocyte function. Nephron 2000; 86:62-9.
12. Szeto C, Chow K, Lam CW, Leung C, Kwan BC, Chung K, et al. Clinical biocompatibility of a neutral peritoneal dialysis solution with minimal glucose-degradation products - a 1-year randomized control trial. Nephrol Dial Transplant 2007; 22:552-9.
13. Lee HY, Park HC, Seo BJ, Do JY, Yun SR, Song HY, et al. Superior patient survival for continuous ambulatory peritoneal dialysis patients treated with a peritoneal dialysis fluid with neutral pH and low degradation product concentration (balance). Perit Dial Int 2005; 25:248-55.
14. Montenegro J, Saracho R, Gallardo I, Martínez I, Munoz R, Quintanilla N. Use of pure bicarbonate-buffered peritoneal dialysis fluid reduces the incidence of CAPD peritonitis. Nephrol Dial Transplant 2007; 22:1703-8.